| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
66,607 |
57,936 |
$30.23M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
53,711 |
46,998 |
$16.33M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
63,618 |
55,446 |
$13.38M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
53,677 |
44,374 |
$7.58M |
| S9480 |
Intensive outpatient psychiatric services, per diem |
42,597 |
6,510 |
$4.70M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12,986 |
12,124 |
$3.72M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
5,358 |
5,079 |
$3.25M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
4,692 |
4,382 |
$2.90M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12,305 |
11,202 |
$2.53M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
33,060 |
10,517 |
$2.06M |
| 70450 |
Computed tomography, head or brain; without contrast material |
16,699 |
14,929 |
$2.01M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
34,435 |
27,470 |
$1.87M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
24,795 |
17,767 |
$1.82M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,531 |
2,278 |
$1.75M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,701 |
1,640 |
$1.58M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12,156 |
8,148 |
$1.53M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,805 |
10,714 |
$1.52M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
10,797 |
8,952 |
$1.51M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,780 |
1,707 |
$1.42M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
8,781 |
3,873 |
$1.41M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
34,374 |
27,503 |
$1.39M |
| 71046 |
Radiologic examination, chest; 2 views |
22,327 |
20,327 |
$1.31M |
| J9271 |
Injection, pembrolizumab, 1 mg |
197 |
140 |
$1.31M |
| 93458 |
|
952 |
885 |
$1.31M |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
1,820 |
1,096 |
$1.10M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,092 |
2,784 |
$1.02M |
| 71045 |
Radiologic examination, chest; single view |
21,218 |
18,498 |
$997K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
7,303 |
6,663 |
$964K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
14,860 |
12,677 |
$942K |
| G0379 |
Direct admission of patient for hospital observation care |
1,660 |
1,275 |
$792K |
| 47562 |
|
179 |
161 |
$738K |
| J0897 |
Injection, denosumab, 1 mg |
713 |
613 |
$728K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
6,485 |
5,944 |
$726K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,946 |
5,569 |
$612K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,487 |
5,294 |
$585K |
| 27447 |
|
126 |
108 |
$491K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,635 |
3,327 |
$456K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
749 |
718 |
$447K |
| 59025 |
Fetal non-stress test |
2,659 |
1,498 |
$433K |
| 93350 |
|
1,014 |
959 |
$401K |
| 76801 |
|
3,590 |
3,161 |
$378K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,092 |
4,310 |
$362K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
448 |
435 |
$354K |
| 93017 |
|
8,534 |
7,847 |
$351K |
| 76830 |
Ultrasound, transvaginal |
3,368 |
3,123 |
$341K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,477 |
2,231 |
$325K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
23,177 |
7,802 |
$318K |
| 76641 |
|
3,499 |
3,339 |
$318K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,167 |
2,924 |
$290K |
| 93798 |
|
3,991 |
582 |
$280K |
| 90791 |
Psychiatric diagnostic evaluation |
2,625 |
2,274 |
$254K |
| 93971 |
|
3,596 |
3,246 |
$247K |
| 97161 |
|
5,035 |
4,520 |
$233K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
11,320 |
9,611 |
$226K |
| 93976 |
|
2,126 |
1,867 |
$211K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,185 |
2,001 |
$195K |
| 93975 |
|
828 |
768 |
$181K |
| 93351 |
|
427 |
409 |
$179K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,062 |
1,928 |
$177K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
796 |
723 |
$164K |
| 10061 |
|
529 |
478 |
$153K |
| 93970 |
|
1,180 |
1,085 |
$150K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,314 |
2,524 |
$149K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,391 |
3,064 |
$144K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
1,394 |
1,198 |
$143K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,035 |
3,694 |
$134K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
12,663 |
4,250 |
$134K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,495 |
1,309 |
$133K |
| 97597 |
|
1,809 |
1,116 |
$131K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
1,121 |
711 |
$129K |
| 77065 |
Tomosynthesis, mammo |
1,179 |
1,072 |
$128K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
907 |
823 |
$125K |
| 86900 |
|
11,287 |
9,512 |
$119K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
209 |
169 |
$119K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18,950 |
14,185 |
$107K |
| 97162 |
|
1,997 |
1,885 |
$106K |
| 71250 |
|
2,431 |
2,210 |
$105K |
| 76642 |
|
1,641 |
1,530 |
$104K |
| 29580 |
|
1,614 |
639 |
$103K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
148 |
141 |
$101K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
280 |
252 |
$98K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
22,605 |
7,391 |
$92K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
12,016 |
5,199 |
$91K |
| 96415 |
|
1,377 |
897 |
$90K |
| 0002A |
|
2,874 |
2,715 |
$88K |
| 0001A |
|
3,103 |
2,856 |
$87K |
| 96367 |
|
1,871 |
1,162 |
$87K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
551 |
515 |
$83K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,112 |
1,531 |
$82K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
721 |
674 |
$78K |
| 77066 |
Tomosynthesis, mammo |
639 |
611 |
$76K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,385 |
5,193 |
$76K |
| 72100 |
|
4,108 |
3,770 |
$73K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,842 |
1,732 |
$72K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
294 |
275 |
$69K |
| 80053 |
Comprehensive metabolic panel |
62,215 |
49,407 |
$67K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
121,642 |
93,037 |
$66K |
| 96417 |
|
1,225 |
697 |
$65K |
| 15271 |
|
69 |
37 |
$63K |
| 77336 |
|
881 |
357 |
$59K |
| 76857 |
|
626 |
586 |
$58K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,257 |
891 |
$56K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
211 |
200 |
$56K |
| 70496 |
|
409 |
373 |
$56K |
| 97010 |
|
992 |
589 |
$56K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
6,656 |
6,010 |
$55K |
| 36430 |
|
382 |
234 |
$54K |
| 76770 |
|
655 |
611 |
$53K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
694 |
635 |
$48K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
587 |
224 |
$47K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
52,992 |
44,729 |
$47K |
| 97165 |
|
825 |
734 |
$45K |
| 97116 |
|
1,818 |
1,083 |
$44K |
| 72131 |
|
1,527 |
1,402 |
$44K |
| G0498 |
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion |
320 |
151 |
$41K |
| Q0222 |
Injection, bebtelovimab, 175 mg |
161 |
150 |
$41K |
| 73630 |
|
3,714 |
3,331 |
$39K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,048 |
982 |
$38K |
| 73560 |
|
5,255 |
4,812 |
$38K |
| 82728 |
|
6,108 |
5,378 |
$38K |
| 74174 |
|
243 |
219 |
$35K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
21 |
12 |
$35K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
183 |
120 |
$34K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
1,160 |
774 |
$33K |
| 94060 |
|
168 |
160 |
$32K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
160 |
149 |
$32K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
296 |
187 |
$31K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,234 |
2,965 |
$29K |
| 76536 |
|
436 |
414 |
$29K |
| 70486 |
|
1,769 |
1,609 |
$29K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
479 |
173 |
$29K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
710 |
630 |
$29K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,215 |
2,948 |
$28K |
| 90837 |
Psychotherapy, 53 minutes with patient |
306 |
145 |
$27K |
| 77334 |
|
94 |
41 |
$26K |
| 11043 |
|
76 |
39 |
$24K |
| 83550 |
|
5,847 |
5,194 |
$24K |
| 82607 |
|
3,449 |
3,146 |
$24K |
| 96402 |
|
906 |
684 |
$24K |
| 72040 |
|
1,813 |
1,634 |
$24K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
200 |
128 |
$21K |
| 96411 |
|
499 |
277 |
$20K |
| 73030 |
|
4,007 |
3,576 |
$20K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
67 |
61 |
$20K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,062 |
1,422 |
$19K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
22,284 |
18,868 |
$19K |
| 83540 |
|
6,153 |
5,252 |
$18K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,366 |
1,295 |
$18K |
| 72132 |
|
712 |
634 |
$17K |
| 73502 |
|
2,168 |
1,977 |
$17K |
| 97535 |
Self-care/home management training, each 15 minutes |
2,153 |
1,180 |
$17K |
| J0185 |
Injection, aprepitant, 1 mg |
150 |
87 |
$17K |
| 73610 |
|
3,040 |
2,758 |
$15K |
| 73700 |
|
274 |
263 |
$15K |
| 82746 |
|
1,791 |
1,622 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
70,246 |
52,334 |
$13K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
136 |
101 |
$13K |
| 74240 |
|
99 |
92 |
$12K |
| 70491 |
|
81 |
76 |
$12K |
| 74183 |
|
65 |
62 |
$12K |
| 93296 |
|
1,152 |
1,130 |
$11K |
| 73130 |
|
3,574 |
3,220 |
$11K |
| 93312 |
|
82 |
78 |
$11K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
40 |
38 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12,398 |
10,965 |
$9K |
| C9088 |
Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg |
83 |
77 |
$9K |
| 72141 |
|
62 |
52 |
$9K |
| 99215 |
Prolong outpt/office vis |
74 |
46 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
59,101 |
46,811 |
$8K |
| 83615 |
|
3,621 |
2,545 |
$8K |
| G0378 |
Hospital observation service, per hour |
14,459 |
8,072 |
$8K |
| 86923 |
|
588 |
367 |
$8K |
| 78451 |
|
36 |
31 |
$7K |
| 72128 |
|
578 |
534 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,188 |
10,767 |
$7K |
| 93298 |
|
516 |
478 |
$7K |
| 97166 |
|
91 |
90 |
$6K |
| 0004A |
|
298 |
298 |
$6K |
| 12001 |
|
1,130 |
1,054 |
$6K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
22 |
20 |
$6K |
| 73110 |
|
1,841 |
1,668 |
$6K |
| 0064A |
|
163 |
162 |
$6K |
| 77300 |
|
57 |
24 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
386 |
359 |
$5K |
| 72070 |
|
310 |
283 |
$5K |
| 36591 |
|
266 |
161 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
10,670 |
8,017 |
$4K |
| 93297 |
|
275 |
268 |
$4K |
| 97163 |
|
84 |
74 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,392 |
2,018 |
$4K |
| 77080 |
|
38 |
38 |
$4K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
16 |
12 |
$4K |
| 80076 |
|
29,146 |
25,181 |
$4K |
| 83735 |
|
24,861 |
19,743 |
$4K |
| 74018 |
|
1,591 |
1,404 |
$4K |
| 87641 |
|
948 |
887 |
$3K |
| 12011 |
|
494 |
466 |
$3K |
| 82378 |
|
822 |
639 |
$3K |
| 82784 |
|
332 |
296 |
$3K |
| 84165 |
|
659 |
554 |
$3K |
| 0012A |
|
131 |
121 |
$3K |
| 0031A |
|
132 |
90 |
$3K |
| 77061 |
|
233 |
214 |
$3K |
| 10060 |
|
20 |
14 |
$3K |
| 77085 |
|
44 |
39 |
$3K |
| 86320 |
|
302 |
268 |
$2K |
| 83521 |
|
377 |
340 |
$2K |
| 93290 |
|
180 |
175 |
$2K |
| 0011A |
|
115 |
105 |
$2K |
| 73070 |
|
592 |
538 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,304 |
2,076 |
$2K |
| 86850 |
|
11,091 |
9,493 |
$2K |
| 74019 |
|
581 |
512 |
$2K |
| 93242 |
|
101 |
99 |
$2K |
| 83880 |
|
12,186 |
10,347 |
$2K |
| 80061 |
Lipid panel |
241 |
223 |
$2K |
| 81025 |
|
31,518 |
27,992 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12,644 |
10,540 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,333 |
3,145 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
24 |
24 |
$2K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,289 |
1,220 |
$2K |
| 85610 |
|
19,728 |
17,035 |
$2K |
| 74021 |
|
837 |
786 |
$2K |
| 85730 |
|
6,543 |
5,811 |
$2K |
| 84134 |
|
458 |
431 |
$2K |
| 72110 |
|
27 |
27 |
$2K |
| 73590 |
|
1,070 |
938 |
$1K |
| 86901 |
|
11,283 |
9,512 |
$1K |
| 97035 |
|
27 |
14 |
$1K |
| 71101 |
|
475 |
429 |
$1K |
| 84439 |
|
1,541 |
1,326 |
$1K |
| 12002 |
|
302 |
283 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14,488 |
12,220 |
$1K |
| 87070 |
|
3,755 |
3,269 |
$1K |
| 76813 |
|
1,454 |
1,355 |
$1K |
| 0003A |
|
33 |
33 |
$1K |
| 87186 |
|
5,425 |
4,815 |
$1K |
| 76870 |
|
173 |
155 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,828 |
7,731 |
$965.68 |
| 81003 |
|
45,106 |
39,461 |
$941.06 |
| 85651 |
|
1,585 |
1,253 |
$929.19 |
| 73562 |
|
41 |
38 |
$894.16 |
| 82947 |
|
476 |
407 |
$869.24 |
| 77062 |
|
73 |
71 |
$869.20 |
| 88342 |
|
657 |
533 |
$843.93 |
| 0071A |
|
22 |
22 |
$800.00 |
| 85045 |
|
492 |
394 |
$780.84 |
| 86140 |
|
1,364 |
1,147 |
$768.76 |
| 0124A |
|
26 |
26 |
$760.00 |
| 0072A |
|
21 |
21 |
$760.00 |
| 85027 |
|
5,873 |
4,610 |
$750.18 |
| 84484 |
|
41,614 |
30,313 |
$721.89 |
| 87088 |
|
6,539 |
5,897 |
$681.44 |
| 88307 |
|
1,305 |
1,082 |
$660.42 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
784 |
742 |
$659.97 |
| 86920 |
|
33 |
27 |
$645.40 |
| 29581 |
|
18 |
12 |
$633.31 |
| 72170 |
|
870 |
782 |
$632.92 |
| 84702 |
|
3,655 |
3,084 |
$622.52 |
| 83690 |
|
34,713 |
30,274 |
$617.24 |
| 82565 |
|
3,738 |
2,567 |
$609.20 |
| 90715 |
|
1,987 |
1,798 |
$587.05 |
| 36600 |
|
477 |
420 |
$559.95 |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
350 |
306 |
$545.78 |
| 87205 |
|
3,841 |
3,278 |
$529.94 |
| 87075 |
|
810 |
677 |
$527.79 |
| 93880 |
|
12 |
12 |
$472.15 |
| 70498 |
|
393 |
358 |
$452.34 |
| 87077 |
|
4,386 |
3,869 |
$416.91 |
| 83883 |
|
62 |
41 |
$415.36 |
| 87400 |
|
9,987 |
4,769 |
$409.82 |
| 0034A |
|
12 |
12 |
$400.00 |
| 83605 |
|
18,444 |
14,212 |
$385.31 |
| 82805 |
|
4,934 |
4,160 |
$352.37 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,332 |
2,012 |
$315.46 |
| 87081 |
|
3,386 |
3,143 |
$312.55 |
| 94726 |
|
106 |
105 |
$310.80 |
| 86334 |
|
41 |
39 |
$306.42 |
| 86780 |
|
30 |
28 |
$303.36 |
| 73090 |
|
380 |
338 |
$298.54 |
| J1756 |
Injection, iron sucrose, 1 mg |
1,420 |
636 |
$292.00 |
| 73080 |
|
233 |
205 |
$270.34 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
65,325 |
48,792 |
$266.77 |
| J3490 |
Unclassified drugs |
250,413 |
86,044 |
$264.29 |
| 82570 |
|
356 |
276 |
$261.82 |
| 81001 |
|
10,230 |
9,096 |
$239.24 |
| 90686 |
|
43 |
41 |
$237.36 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
22,228 |
19,454 |
$217.29 |
| 87040 |
|
6,986 |
3,654 |
$208.53 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
392 |
232 |
$205.30 |
| 29125 |
|
332 |
306 |
$200.99 |
| 88313 |
|
3,424 |
3,016 |
$194.21 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
14 |
13 |
$185.40 |
| 73060 |
|
27 |
26 |
$182.42 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
1,314 |
861 |
$178.52 |
| 73140 |
|
24 |
24 |
$174.66 |
| 20561 |
|
32 |
12 |
$167.10 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
87 |
80 |
$162.00 |
| 84156 |
|
264 |
201 |
$157.50 |
| 88304 |
|
1,804 |
1,643 |
$145.27 |
| 82550 |
|
6,190 |
5,352 |
$139.63 |
| 85379 |
|
3,275 |
2,994 |
$129.82 |
| 96376 |
|
8,117 |
5,827 |
$119.17 |
| 86618 |
|
130 |
122 |
$113.89 |
| 84100 |
|
4,975 |
4,052 |
$110.70 |
| 82248 |
|
146 |
109 |
$103.21 |
| 84703 |
|
606 |
559 |
$100.52 |
| 86300 |
|
13 |
12 |
$99.35 |
| 83010 |
|
22 |
13 |
$96.08 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
511 |
479 |
$90.84 |
| Q9954 |
Oral magnetic resonance contrast agent, per 100 ml |
2,513 |
1,910 |
$90.44 |
| 84550 |
|
1,302 |
1,049 |
$88.02 |
| 70360 |
|
13 |
12 |
$69.46 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
39,815 |
32,802 |
$64.73 |
| 84520 |
|
2,856 |
1,762 |
$63.42 |
| 80051 |
|
2,312 |
1,486 |
$60.30 |
| 84152 |
|
12 |
12 |
$52.68 |
| 82077 |
|
1,048 |
967 |
$47.45 |
| 85014 |
|
249 |
173 |
$45.20 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
20,217 |
15,892 |
$43.84 |
| 85018 |
|
377 |
243 |
$42.94 |
| 87420 |
|
604 |
562 |
$36.54 |
| 83655 |
|
23 |
19 |
$34.68 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,710 |
1,781 |
$32.21 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,996 |
2,618 |
$31.84 |
| 82150 |
|
785 |
723 |
$30.95 |
| 84132 |
|
197 |
170 |
$26.92 |
| J3360 |
Injection, diazepam, up to 5 mg |
1,870 |
1,639 |
$26.87 |
| 84145 |
|
51 |
42 |
$25.58 |
| J1790 |
Injection, droperidol, up to 5 mg |
2,138 |
1,800 |
$22.87 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
13,175 |
10,300 |
$20.24 |
| 86308 |
|
544 |
508 |
$18.62 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
31,160 |
25,265 |
$17.63 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12,891 |
10,053 |
$13.97 |
| 87184 |
|
500 |
445 |
$13.18 |
| 80164 |
|
539 |
489 |
$12.94 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
7,531 |
5,754 |
$11.96 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
12,099 |
8,422 |
$11.68 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
8,298 |
5,924 |
$10.48 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
23,101 |
19,698 |
$10.31 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
6,303 |
5,346 |
$10.12 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
647 |
563 |
$9.96 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
9,273 |
7,273 |
$8.79 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
798 |
637 |
$8.40 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
6,454 |
5,617 |
$8.06 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
14,114 |
12,418 |
$7.87 |
| 82010 |
|
717 |
612 |
$7.80 |
| J1644 |
Injection, heparin sodium, per 1000 units |
6,253 |
3,561 |
$7.75 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
15 |
12 |
$6.27 |
| J2704 |
Injection, propofol, 10 mg |
27,778 |
20,170 |
$5.85 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
12,887 |
11,397 |
$5.30 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,338 |
1,507 |
$5.28 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
13 |
12 |
$5.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,488 |
613 |
$4.42 |
| J2060 |
Injection, lorazepam, 2 mg |
4,305 |
3,459 |
$4.17 |
| J7050 |
Infusion, normal saline solution, 250 cc |
8,891 |
4,678 |
$4.06 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
3,805 |
2,886 |
$3.93 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
279 |
253 |
$3.59 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
2,295 |
1,620 |
$2.90 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
7,540 |
5,516 |
$2.68 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
4,748 |
3,430 |
$2.64 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
3,300 |
2,487 |
$2.28 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,478 |
1,233 |
$1.98 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
3,984 |
1,393 |
$1.82 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,382 |
1,124 |
$1.60 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
200 |
173 |
$1.02 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
820 |
765 |
$1.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
194 |
170 |
$0.98 |
| 90672 |
|
45 |
42 |
$0.40 |
| J1836 |
Injection, metronidazole, 10 mg |
264 |
175 |
$0.32 |
| J7510 |
Prednisolone oral, per 5 mg |
476 |
438 |
$0.22 |
| 90670 |
|
24 |
21 |
$0.20 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,391 |
1,084 |
$0.04 |
| 88312 |
|
6,477 |
5,482 |
$0.00 |
| 99152 |
|
2,673 |
2,344 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
26 |
24 |
$0.00 |
| C1776 |
Joint device (implantable) |
824 |
746 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
1,039 |
918 |
$0.00 |
| 93356 |
|
111 |
103 |
$0.00 |
| 82009 |
|
648 |
569 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,442 |
1,247 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
696 |
174 |
$0.00 |
| 0055T |
|
31 |
27 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,568 |
933 |
$0.00 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
138 |
95 |
$0.00 |
| 72129 |
|
512 |
463 |
$0.00 |
| 80143 |
|
130 |
118 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
33 |
28 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
120 |
107 |
$0.00 |
| 94729 |
|
148 |
147 |
$0.00 |
| 93325 |
|
76 |
73 |
$0.00 |
| 76376 |
|
62 |
59 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
108 |
106 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
32 |
25 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,247 |
2,007 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
218 |
187 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
184 |
152 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
902 |
857 |
$0.00 |
| 85347 |
|
184 |
132 |
$0.00 |
| 91300 |
|
5,783 |
4,922 |
$0.00 |
| J1245 |
Injection, dipyridamole, per 10 mg |
907 |
835 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
682 |
160 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
410 |
341 |
$0.00 |
| 80179 |
|
127 |
112 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
16 |
12 |
$0.00 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
17 |
14 |
$0.00 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
102 |
68 |
$0.00 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
50 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
258 |
184 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
35 |
33 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
25 |
25 |
$0.00 |
| 90461 |
|
45 |
38 |
$0.00 |
| C1729 |
Catheter, drainage |
14 |
12 |
$0.00 |
| 51702 |
|
12 |
12 |
$0.00 |
| 91312 |
|
13 |
13 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,849 |
2,236 |
$0.00 |
| 96040 |
|
314 |
296 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
1,671 |
1,301 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
981 |
742 |
$0.00 |
| C1769 |
Guide wire |
2,926 |
2,532 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
4,960 |
4,638 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
2,308 |
2,020 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
6,289 |
2,707 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
2,997 |
2,814 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,614 |
2,319 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,422 |
1,267 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
510 |
417 |
$0.00 |
| C1781 |
Mesh (implantable) |
132 |
127 |
$0.00 |
| 11045 |
|
566 |
263 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,557 |
828 |
$0.00 |
| 90698 |
|
21 |
18 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
2,492 |
1,063 |
$0.00 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
989 |
915 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
819 |
733 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
993 |
788 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
62 |
53 |
$0.00 |
| 91303 |
|
82 |
76 |
$0.00 |
| 96368 |
|
499 |
288 |
$0.00 |
| J2305 |
Injection, nitroglycerin, 5 mg |
252 |
241 |
$0.00 |
| 88341 |
|
217 |
158 |
$0.00 |
| A6213 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
245 |
212 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
126 |
98 |
$0.00 |
| 90674 |
|
19 |
17 |
$0.00 |
| 91305 |
|
26 |
26 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
344 |
305 |
$0.00 |
| 91307 |
|
43 |
43 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
111 |
106 |
$0.00 |
| 91301 |
|
260 |
244 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
119 |
106 |
$0.00 |
| 73552 |
|
29 |
28 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
99 |
68 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
12 |
12 |
$0.00 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
61 |
38 |
$0.00 |
| 91306 |
|
158 |
157 |
$0.00 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
13 |
13 |
$0.00 |
| 87449 |
|
13 |
13 |
$0.00 |
| Q0247 |
Injection, sotrovimab, 500 mg |
23 |
23 |
$0.00 |
| 87807 |
|
132 |
126 |
$0.00 |
| 88300 |
|
13 |
12 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
29 |
25 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
16 |
15 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
53 |
51 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
13 |
13 |
$0.00 |
| 74420 |
|
17 |
15 |
$0.00 |
| 88311 |
|
19 |
14 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
13 |
13 |
$0.00 |